statistiche ricercatore

NAPOLITANO, FABIANA

Distribuzione geografica

Continente	#
AS - Asia	1.284
EU - Europa	1.020
NA - Nord America	942
SA - Sud America	134
AF - Africa	31
OC - Oceania	2
Totale	3.413

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	882
SG - Singapore	484
RU - Federazione Russa	398
IT - Italia	364
CN - Cina	267
VN - Vietnam	252
BR - Brasile	108
DE - Germania	93
HK - Hong Kong	88
IN - India	47
BD - Bangladesh	44
FR - Francia	39
CA - Canada	34
NL - Olanda	32
FI - Finlandia	27
JP - Giappone	26
KR - Corea	21
GB - Regno Unito	19
CI - Costa d'Avorio	14
MX - Messico	14
AR - Argentina	13
PK - Pakistan	13
ZA - Sudafrica	8
IQ - Iraq	7
PL - Polonia	7
UA - Ucraina	7
BE - Belgio	6
SE - Svezia	6
EC - Ecuador	5
ES - Italia	5
TH - Thailandia	5
UZ - Uzbekistan	5
CR - Costa Rica	4
ID - Indonesia	4
MY - Malesia	4
TR - Turchia	4
VE - Venezuela	4
IL - Israele	3
LT - Lituania	3
AT - Austria	2
AU - Australia	2
CL - Cile	2
CZ - Repubblica Ceca	2
EG - Egitto	2
PH - Filippine	2
PT - Portogallo	2
PY - Paraguay	2
SV - El Salvador	2
TN - Tunisia	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AZ - Azerbaigian	1
BF - Burkina Faso	1
BG - Bulgaria	1
CG - Congo	1
CH - Svizzera	1
CY - Cipro	1
DZ - Algeria	1
EE - Estonia	1
GR - Grecia	1
GT - Guatemala	1
HN - Honduras	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
KN - Saint Kitts e Nevis	1
MD - Moldavia	1
OM - Oman	1
PA - Panama	1
RO - Romania	1
RS - Serbia	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
ZM - Zambia	1
Totale	3.413

Salva come PNG Salva come JPEG

Città	#
Singapore	258
San Jose	177
Naples	151
Ashburn	109
Hefei	100
Ho Chi Minh City	87
Hong Kong	85
Moscow	83
Beijing	67
Santa Clara	53
Dallas	49
Hanoi	43
Munich	43
Chandler	39
Los Angeles	28
Lauterbourg	24
Kochi	23
Amsterdam	22
Tokyo	21
The Dalles	20
New York	19
Seoul	17
Da Nang	16
São Paulo	16
Turku	16
Napoli	15
Rome	15
Council Bluffs	14
Buffalo	12
Frankfurt am Main	12
Toronto	12
Falkenstein	11
Haiphong	10
Millbury	10
Redondo Beach	10
Boston	9
Helsinki	9
Lawrence	9
Milan	9
Pune	9
Montreal	8
Seattle	8
Turin	8
Brooklyn	7
Mexico City	7
Ninh Bình	7
Warsaw	7
Casoria	6
Des Moines	6
Houston	6
Nuremberg	6
Orem	6
Atlanta	5
Johannesburg	5
London	5
Stockholm	5
Tashkent	5
Baghdad	4
Bologna	4
Brussels	4
Chicago	4
Düsseldorf	4
Formia	4
Fucecchio	4
Lahore	4
Long Xuyen	4
Poplar	4
Quảng Ngãi	4
Salerno	4
Shanghai	4
Belo Horizonte	3
Can Tho	3
Casagiove	3
Charlotte	3
Chengdu	3
Chennai	3
Fort Worth	3
Guayaquil	3
Hải Dương	3
Islamabad	3
Kuala Lumpur	3
Ottawa	3
Piscataway	3
Pomigliano d'Arco	3
Pozzuoli	3
Quận Ba	3
Redwood City	3
Acalanes Ridge	2
Afragola	2
Ankara	2
Aurora	2
Bari	2
Bengaluru	2
Biên Hòa	2
Boardman	2
Buenos Aires	2
Calgary	2
Denver	2
Fairfield	2
Gravataí	2
Totale	1.968

Salva come PNG Salva come JPEG

Nome	#
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists	195
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity	189
Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors	167
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer	167
Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations	160
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review.	160
Tumour microenvironment and immune evasion in EGFR addicted NSCLC: Hurdles and possibilities	159
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules	154
Use of folfirinox or nab-paclitaxel plus gemcitabine for the treatment of locally advanced pancreatic adenocarcinoma: A single institution observational study	153
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma	151
Mechanisms of resistance to mTOR inhibitors	145
A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2- breast cancer	143
RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges	142
Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: a systematic review	141
Role of FGFR3 in bladder cancer: Treatment landscape and future challenges	135
Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer	135
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer	132
FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study	129
EGFR and HER2 hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer	123
Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC	123
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis	121
Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes	105
AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors	99
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer	93
Censoring in trials testing immunotherapy in advanced cancers: a systematic review and a meta-research study	12
CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer	10
Performance of Control Arms in Trials Leading to FDA Cancer Drug Approvals	9
Quality of life results and survival outcomes in trials of immunotherapy in advanced cancers: A systematic review and meta-research study	8
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysis	5
Shaping CDK4/6 Inhibitor Resistance: BRCA2 Germline Alterations Bias toward RB1 Inactivation	4
Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations	3
A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer	2
Mapping cellular interactions from spatially resolved transcriptomics data	2
ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor–Positive Breast Cancer	2
Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer	1
Totale	3.479

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	10.692
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	10.692

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	80	0	0	9	7	1	3	3	4	4	7	20	22
2022/2023	180	15	10	5	3	19	16	12	20	30	25	14	11
2023/2024	190	4	18	43	16	7	32	3	22	6	6	16	17
2024/2025	948	28	21	5	17	26	75	90	82	49	138	336	81
2025/2026	1.945	192	148	251	160	290	82	201	93	228	109	68	123
2026/2027	38	38	0	0	0	0	0	0	0	0	0	0	0
Totale													3.479